Blaze Biosciences Raises $8.5M

Seattle-based Blaze Bioscience announced this morning that it has raised $8.5M in a Series A funding round. The firm said the funding came from individual investors, including physicians and biotech executives. The firm said it has now raised $9.8M in funding. Blaze Biosciences is developing surgical oncology products, which help surgeons distinguish cancer cells from healthy cells in brain cancer. Blaze said the new funds will go towards clinical development and advancement of its product, and also go towards expanding its leadership team and establishing a corporate headquarters and laboratory in the South Lake Union area. More information »